Supernus Pharmaceuticals Inc (SUPN) Q1 2020 Earnings Call Transcript
SUPN earnings call for the period ending March 31, 2020.
Supernus Pharmaceuticals
SUPN
SUPN
$23.90
$0.14
0.6%
Price as of July 14, 2020, 4:30 p.m. EDT
View Interactive SUPN Charts
Supernus Pharmaceuticals Inc specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system or CNS diseases.
Interactive Chart
News & Analysis: Supernus Pharmaceuticals
Your 2 Top Profit Opportunities in 2020
These two underrated biotech stocks have the potential to soar.
Why Supernus Pharmaceuticals Plunged 15% Today
Shares slumped after the commercial-stage biopharma reported mixed results.
Supernus Pharmaceuticals Inc (SUPN) Q4 2019 Earnings Call Transcript
SUPN earnings call for the period ending December 31, 2019.
Supernus Pharmaceuticals Inc (SUPN) Q3 2019 Earnings Call Transcript
SUPN earnings call for the period ending September 30, 2019.
Supernus Pharmaceuticals Inc (SUPN) Q2 2019 Earnings Call Transcript
SUPN earnings call for the period ending June 30, 2019.
3 Top Value Stocks to Buy in May
Deep-value stocks like Supernus Pharmaceuticals and Party City look attractive now.
Supernus Pharmaceuticals Inc (SUPN) Q1 2019 Earnings Call Transcript
SUPN earnings call for the period ending March 24, 2019.
2 Incredibly Cheap Value Stocks to Buy Now
Exelixis and Supernus Pharmaceuticals are deeply undervalued healthcare plays.
Supernus Pharmaceuticals Inc (SUPN) Q4 2018 Earnings Conference Call Transcript
SUPN earnings call for the period ending December 31, 2018.
